What's New in Regulatory Science Newsletter

This issue contains updates on CDER's COVID19 response, research news from CDER offices & other regulatory science efforts that help advance

Receive this email as a forward? Subscribe to CDER SBIA industry updates. FDA | CDER | Small Business and Industry Assistance INDUSTRY NEWS . What's New in Regulatory Science Newsletter   Check out the first issue of 2022 of the What's New In Regulatory Science newsletter from the Food and Drug Administration's (FDA's) Center for Drug Evaluation and Research (CDER). This issue contains updates on CDER's COVID-19 response, research news from CDER offices & other regulatory science efforts that help advance medical product development.   Read More The Small Business and Industry Assistance (SBIA) program in the Center for Drug Evaluation and Research  provides guidance, education and updates for regulated industry. Subscribe to CDER SBIA Email Updates Register for Upcoming Training View 2021 Recordings on YouTube Follow on LinkedIn Follow on Twitter This is an automated message delivery system. Replying to this message will not reach the CDER SBIA staff. If you have comments or questions, contact us at CDERSBIA@fda.hhs.gov or 1-866-405-5367 or (301) 796-6707.  SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA